Autres langues Akoya Biosciences, Inc.

Actions

AKYA

US00974H1041

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 07/05/2024			Varia. 5j.	Varia. 1 janv.
4,08 ^USD	-0,97%		+6,81%	-16,39%

06/05	Akoya Biosciences ouvre un centre d'excellence pour les opérations et la fabrication à Marlborough, Massachusetts	CI
02/05	Akoya Biosciences et Shanghai KR Pharmtech annoncent l'approbation de pré-commercialisation de l'Agence réglementaire chinoise pour le KR-HT5 en Chine, afin de soutenir les flux de travail cliniques de la pathologie de nouvelle génération.	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts	06/05
Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts	06/05
Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts	06/05
Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows	02/05
Akoya Biosciences and Shanghai KR Pharmtech Announces Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows	02/05
Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024	22/04
Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale	05/04
Akoya Biosciences Showcases Spatial Biology 2.0 Solutions At AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale	05/04
Akoya Biosciences Names BostonGene as a Qualified CRO Service Provider	20/03
Akoya Biosciences, Inc. Provides Revenue Guidance for the Full Year 2024	04/03
Akoya: Q4 Earnings Snapshot	04/03
Earnings Flash (AKYA) AKOYA BIOSCIENCES Posts Q4 Revenue $26.5M, vs. Street Est of $26.1M	04/03
Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook	04/03
Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook	04/03
Akoya Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	04/03
North American Morning Briefing : Stock Futures -2-	04/03
Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference	08/02
Akoya Biosciences Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases	19/01
Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases	18/01
Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases	18/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Akoya Biosciences, Inc.

Actions

AKYA

US00974H1041

Autres langues

Filtres